Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$0.66 - $1.81 $26,598 - $72,943
-40,300 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$2.61 - $4.17 $3,654 - $5,838
1,400 Added 3.6%
40,300 $135,000
Q1 2021

May 13, 2021

BUY
$2.91 - $4.32 $4,801 - $7,128
1,650 Added 4.43%
38,900 $121,000
Q3 2020

Nov 13, 2020

BUY
$2.77 - $6.17 $692 - $1,542
250 Added 0.68%
37,250 $107,000
Q1 2020

May 18, 2020

BUY
$0.73 - $1.91 $27,010 - $70,670
37,000 New
37,000 $35,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.